MAPT and Alzheimer disease: Injected AD brain extracts into this mouse model showed stronger interaction with humanized tau compared to mice with endogenous mouse tau, presenting this model as an attractive candidate for elucidating AD disease mechanisms by injection of patient-derived brain homogenates.